PayPal co-founder and Donald Trump donor Peter Thiel is allegedly into this new fetish,
$8K a liter: Strange new startup harvests young blood to sell to the rich
Will Someone please inform Gwyneth Paltrow to stop Upskirting, but have a pint or two of fresh young blood instead?
Ambrosia, founded in 2016 by Stanford Medical School graduate Jesse Karmazin, has already established transfusion centers in five cities across the US: Los Angeles, Tampa, Omaha, Houston, and San Francisco. Their ghoulish-sounding treatments start at just $8,000 for one liter, and $12,000 for two.
The blood donors range in age from 16 to 25, while patients fall into the over 30s bracket. So far, roughly 150 patients aged 35 to 92 have reportedly undergone the âyoung plasma treatments,â and the company claims a waiting list has already formed.
The idea was inspired by an experimental treatment called âparabiosisâ, which was conducted on mice and showed reduction in two proteins associated with cancer risks, though the study was both inconclusive and limited in scope.  âSome patients got young blood, and others got older blood, and I was able to do some statistics on it, and the results looked really awesome,â Karmazin said previously. âAnd I thought this is the kind of therapy that Iâd want to be available to me.â
So is Kate Moss… Blood in lieu of Upskirt, please.
The company conducted a clinical trial involving 200 participants from June 2016 to January 2018. No results have been posted from the study on the US governmentâs clinical trials website.
âThe trial was an investigational study,â David Cavalier, Ambrosiaâs former chief operating officer, said in September. âWe saw some interesting things, and we do plan to publish that data. And we want to begin to open clinics where the treatment will be made available.â
Also Elizabeth Banks…Â
The company lists nebulous and ill-defined health benefits in patients such as ârenewed focus, better memory and sleep, and improved appearance and muscle tone,â but has yet to provide any empirical data to back up these claims. This also doesnât account for placebo effect â participants merely traveling to the clinic and participating in the study could easily have produced a positive confirmation bias.
âThey quite likely could inflict bodily harm,â UC Berkeley researcher Irina Conboy cautioned to Business Insider. âIt is well known in the medical community â and this is also the reason we donât do transfusions frequently â that in 50 percent of patients there are very bad side effects. You are being infused with somebody elseâs blood and it doesnât match.âIn addition, blood transfusions are listed as âoff-labelâ treatments by the Food and Drug Administration, meaning they are approved as intended but may also be applied as unconventional treatments without the need to demonstrate any of the purported health benefits listed.
Did we just witness flesh or blood leaking out from Kristin Cavallari?